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Abstract 
Background: Typical enteropathogenic Escherichia coli (t-EPEC) are known to cause diarrhea in children but it is 
uncertain whether atypical EPEC (a-EPEC) do, since a-EPEC lack the bundle-forming pilus (bfp) gene that encodes a 
key adherence factor in t-EPEC. In culture-based studies of a-EPEC, the presence of another adherence factor, called 
EHEC factor for adherence/lymphocyte activation inhibitor (efa1/lifA), was strongly associated with diarrhea. Since 
a-EPEC culture is not feasible in clinical laboratories, we designed an efa1/lifA quantitative PCR assay and examined 
whether the presence of efa1/lifA was associated with higher a-EPEC bacterial loads in pediatric diarrheal stool 
samples.
Methods: Fecal samples from children with diarrhea were tested by qPCR for EPEC (presence of eae gene) and for 
shiga toxin genes to exclude enterohemorrhagic E. coli, which also contain the eae gene. EPEC containing samples 
were then tested for the bundle-forming pilus gene found in t-EPEC and efa1/lifA. The eae gene quantity in efa1/lifA-
positive and negative samples was compared.
Results: Thirty-nine of 320 (12%) fecal samples tested positive for EPEC and 38/39 (97%) contained a-EPEC. The 
efa1/lifA gene was detected in 16/38 (42%) a-EPEC samples. The median eae concentration for efa1/lifA positive 
samples was significantly higher than for efa1/lifA negative samples (median 16,745 vs. 1183 copies/µL, respectively, 
p = 0.006).
Conclusions: Atypical enteropathogenic E. coli-positive diarrheal stool samples containing the efa1/lifA gene had 
significantly higher bacterial loads than samples lacking this gene. This supports the idea that efa1/lifA contributes 
to diarrheal pathogenesis and suggests that, in EPEC-positive samples, efa/lifA may be a useful additional molecular 
biomarker.
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Background
Enteropathogenic Escherichia coli (EPEC) is not detected 
with the standard stool culture methods used in clini-
cal laboratories for bacterial pathogens, so its relative 
importance as a cause of diarrhea in children has been 
uncertain in the past [1]. With the recent increased use of 
molecular detection methods, however, EPEC has been 
found to be the most frequently detected bacterium in 
patients with diarrhea in developed countries [2, 3].
However, not all EPEC strains have the same ability 
to cause diarrhea. All EPEC and enterohemorrhagic E. 
coli (EHEC) contain the chromosomal E. coli attaching 
and effacing (eae) gene that encodes an outer membrane 
protein called intimin. Intimin mediates attachment to 
epithelial cells and leads to the attaching and effacing 
phenotype. EPEC can be differentiated from EHEC by 
the absence of the shiga toxin (stx) genes that are found 
in EHEC. EPEC is further classified into typical and atyp-
ical strains based on the presence or absence of the E. coli 
adherence factor containing the bundle-forming pilus 
(bfp) gene. EPEC containing the bfp gene are classified as 
typical EPEC (t-EPEC) [1]. Strains lacking bfp are classi-
fied as atypical EPEC (a-EPEC).
Typical enteropathogenic E. coli is accepted as a diar-
rhea pathogen, but the pathogenicity of a-EPEC is con-
troversial. Some studies have shown an association with 
a-EPEC and diarrhea while others have not. In addition, 
a-EPEC can be found in asymptomatic children [4–6]. 
Diarrhea was seen in volunteers who ingested a-EPEC 
but to a lesser degree than in those who ingested t-EPEC 
[7, 8]. This controversy surrounding a-EPEC virulence 
has led to a search for additional gene markers in a-EPEC 
that might indicate pathogenicity. The efa1/lifA gene 
appears to be the leading virulence candidate. Efa1/lifA 
encodes for a large 385  kDa adhesion protein, called 
the EHEC factor for adherence (Efa1) since it was first 
described in an EHEC 0157:H7 strain [9]. Efa1 was found 
to be identical to the lymphocyte inhibitory factor A pro-
tein (lifA) gene that lymphostatin, which inhibits lym-
phocyte proliferation and lymphokine production. The 
designation efa1/lifA was therefore given to the gene.
In study of 182 possible virulence markers in a-EPEC 
cultured strains from Norwegian children, the efa1/lifA 
gene had the strongest statistical association with diar-
rhea [9]. Efa1/lifA was present in 30% of a-EPEC strains 
from children with diarrhea and no strains from chil-
dren without diarrhea (p = 0.0008). In a later study from 
Japan, efa1/lifA was detected in 33% of a-EPEC strains in 
individuals with diarrhea and 13% of those in a healthy 
control group [10]. This difference was statistically sig-
nificant (p < 0.05), and efa1/lifA was the only gene exam-
ined which was significantly associated with diarrhea.
These studies demonstrating the importance of efa1/
lifA were performed using stool cultures for EPEC, but 
this is a labor-intensive process that is not feasible in 
clinical microbiology laboratories, since it requires iso-
lating multiple E. coli colonies in each specimen and 
then testing these individually for the genes of interest. 
We therefore developed a direct fecal efa1/lifA real-time 
quantitative PCR (qPCR) method to determine what 
proportion of fecal specimens containing a-EPEC also 
contained efa1/lifA. We then examined whether a-EPEC 
bacterial loads were higher in children when efa1/lifA-
containing a-EPEC was present. Our hypothesis was that 
since the quantity of EPEC in fecal samples as measured 
by qPCR is associated with disease severity, infection 
with efa1/lifA-containing strains of a-EPEC might lead to 
higher bacterial loads [11].
Of note, work to clarify the pathogenicity of a-EPEC 
has become more crucial in recent years since EPEC are 
now detected by a commercially available molecular diar-
rheal panel, the Biofire FilmArray gastrointestinal panel 
(Biomerieux, Durham, NC) [2, 3]. This panel detects the 
eae gene, but not bfp or efa1/lifA. Since a-EPEC is much 
more likely than t-EPEC to be present in developed coun-
tries, clinicians seeing children with diarrhea whose 
samples test positive for EPEC will face uncertainty as to 
whether the organism detected is the cause of the illness. 
Additional molecular biomarkers that are associated with 
a-EPEC pathogenicity rather than the presence of the eae 
gene alone may therefore be useful.
Methods
Study site and ethics approval
This was a prospective observational study performed 
in the months June–Aug 2010–2013 at the Children’s 
Hospital of Eastern Ontario, Ottawa, ON Canada, a 165 
bed tertiary care hospital serving a catchment area of 
1.5 million. It was decided to collect samples in the sum-
mer months since a seasonal predominance increasing 
in these months has been described for both EPEC and 
EHEC [1, 5].
Ethics approval was obtained for the study from the 
hospital Research Ethics Board (CHEOREB # 12/194X). 
Residual aliquots of fecal samples submitted for bacterial 
stool culture from patients with diarrhea that would oth-
erwise have been discarded were tested by PCR for the 
target bacterial genes described below. All samples sub-
mitted to the laboratory for bacterial stool culture over 
the study period were included in the study.
The results of bacterial stool culture were recorded. 
Fecal samples were saved at −80  °C until nucleic acid 
extraction was performed. All patients were ≤18 years of 
age. According to the ethics approval received, in order 
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to ensure patient anonymity, we did not record patient 
age or gender.
Outcome measures
Our main outcome measure was the difference, if any, 
in a-EPEC bacterial load in efa1/lifA positive vs. nega-
tive samples. The secondary outcome measures were the 
prevalence of a-EPEC and t-EPEC in fecal samples; the 
prevalence of efa1/lifA in samples in which a-EPEC was 
detected; and a comparison of EPEC prevalence to the 
prevalence of bacterial pathogens detected by culture.
Laboratory methods
Culture methods
Fecal samples were collected in Cary-Blair enteric trans-
port medium. Samples were inoculated onto Blood agar 
plate, MacConkey agar plate, Hektoen enteric agar plate, 
Sorbitol MacConkey agar plate, Campylobacter agar 
plate and Selenite broth. The Campylobacter plate was 
placed in a microaerophilic environment at 42 °C. Other 
media were incubated in ambient air at 35 °C. After over-
night incubation, the selenite broth was subcultured onto 
a Hektoen plate. Plates were examined for Salmonella 
species (spp.), Shigella spp., Campylobacter spp., Yers-
inia enterocolitica, E.  coli 0157:H7, Aeromonas spp. Ple-
siomonas shigelloides and Vibrio spp. Possible pathogens 
were identified using standard laboratory methods [12].
PCR methods
DNA was extracted from fecal specimens using auto-
mated device (iPrep, Life Technologies, Carlsbad, CA). 
Extracted DNA was then treated to remove fecal PCR 
inhibitors using a commercial method (Zymo-Spin™ 
IV-µHRC Spin Filter Zymo Research, Irvine, CA).
Primer and 5′ exonuclease probe sequences for the 
study assays (eae, stx1, stx2, bfp and efa1/lifA) are shown 
in Table 1. The efa1/lifA assay was designed for this study 
while other assays had been previously published. Efa1/
lifA assay design was performed using a commercial 
qPCR program (Allele ID, Premier Biosoft, Palo Alto 
CA). The limit of detection of the assay was measured by 
duplicate testing of 10-fold serial dilutions of a synthetic 
oligonucleotide target sequence (Ultramer, IDT, Coral-
ville, IA).
Probe and primer specificity were checked using Basic 
Local Alignment Search Tool (BLAST) sequence searches 
and by testing the assay against the following bacterial 
organisms: Streptococcus pneumoniae American type 
culture collection (ATCC) 49,619, Streptococcus sali-
varius ATCC 13,419 Escherichia coli ATCC 25,922, Hae-
mophilus influenzae ATCC 49,766, H. influenzae ATCC 
49,247, H. parainfluenzae ATCC 7901, Klebsiella pneu-
moniae ATCC 700,603, Moraxella catarrhalis ATCC 
25,238, Staphylococcus aureus ATCC 29,247, Neisseria 
gonorrhoeae ATCC 49,226, N. lactamica ATCC 23,970, 
Pseudomonas aeruginosa ATCC 27,853, Enterococcus 
faecalis ATCC 29,212, S. dysgalactiae subsp. equisimilis, 
S. agalactiae (Group B Streptococcus), S. intermedius, S. 
constellatus, and S. anginosus.
QPCR was performed on all samples for the eae gene 
and for the stx-1 and stx-2 genes to exclude EHEC [12, 14, 
15]. Eae-positive; stx-negative samples were then tested 
for the bfp gene to differentiate t-EPEC and a-EPEC and 
for the efa1/lifA gene. Probes were of the 5-prime exo-
nuclease type and were labelled with fluorescein amidite. 
Four probes were obtained from IDT (Coralville, IA) and 
contained an internal quencher as well as a 3-prime end 
quencher. One probe contained a minor groove binder 
and no internal quencher and was obtained from Life 
Technologies (Carlsbad, CA).
PCR assays were prepared in 20 µL volumes in 96-well 
qPCR plate. Positive and negative controls (no tem-
plate) were performed with each qPCR plate run. QPCR 
plates were covered with MicroAmp® Optical Adhesive 
Film (Life Technologies Carlsbad, CA) to prevent cross-
contamination. QPCR was performed with a 96 well 
fast cycling block on a ViiA7 thermocyler (Life Tech-
nologies) using 40 cycles of 2-temperature thermocyling 
(95  °C ×  3  s and 60  °C ×  30  s). QPCR was considered 
positive for the eae, stx1, stx2, and efa1/lifA genes if the 
cycle threshold value was ≤35 cycles and for the bfp gene 
if the cycle threshold value was ≤30 cycles. Specimens 
Table 1 Gene targets PCR primer and probe sequences
MGB minor groove binder
a Modified from published
Target gene/symbol Forward primer Reverse primer Probe Reference
Intimin (eae) cattgatcaggatttttctggtgata ctcatgcggaaatagccgtta atagtctcgccagtattcgccaccaatacc [11]
Shiga toxin 1(stx1) gtggcattaatactgaattgtcatca gcgtaatcccacggactcttc tctgccggacacatag (MGB) [12]a
Shiga toxin 2 (stx2) gggcagttattttgctgtgga tgttgccgtattaacgaaccc ctatcaggcgcgttttgaccatcttcg [13]
Bundle-forming pilus (bfp) gcatcattccgttgttgg ggaccatgtattatcaaaaacctg ccgccttctgacaagctgtgttgg [14]
EHEC factor for adherence 1/lymphocyte 
inhibitory factor A (efa1/lifA)
tcacaccagaattattacgtcacaca atggtagtcaggtatacatccgtatttc accggcacaatactccagactccagaaga This study
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were classified as containing EPEC if they were eae- posi-
tive and stx-negative, and then as t-EPEC (bfp-positive) 
or a-EPEC (bfp-negative). A-EPEC samples were further 
classified as being efa1/lifA-positive or negative.
Results
The limit of detection for the efa1/lifA assay was approxi-
mately 6 copies/PCR reaction. In comparison, the detec-
tion limit for the eae assay was one log higher at 60 
copies/reaction. There was no cross-reactivity observed 
for the efa1/lifA assay with the non-E. coli bacterial spe-
cies tested.
Three-hundred twenty fecal diarrheal samples were 
tested. The PCR and culture results are shown in Table 2. 
Thirty-nine of 320 (12%) fecal samples tested were found 
to have the EPEC marker profile (eae-positive, stx-nega-
tive). Of these EPEC samples, 38/39 (97%) were a-EPEC 
(bfp-negative), with only one t-EPEC (bfp-positive).
The efa1/lifA gene was detected in 16/38 (42%) a-EPEC 
samples. The median eae concentration in these samples 
was 16,745 copies/µL (range 26–3152,879 copies/µL). For 
the 22 efa1/lifA-negative a-EPEC samples, the median 
eae concentration was 1183 copies/µL (range 9–338,770 
copies/µL). The difference in median copies/µL between 
the two groups was statistically significant (p  =  0.006, 
Wilcoxon two-sample test two-sided).
Bacterial cultures were positive in 27/320 samples 
(8.4%), with 28 organisms detected in total. Other bac-
terial pathogens were detected in 4/38 (10%) a-EPEC-
positive samples. The most common single bacterial 
type identified by culture was Salmonella spp., found in 
13/320 (4%) samples. Only 1 EHEC (an E. coli O157:H7) 
was detected by culture, while one or both stx genes were 
detected by qPCR in five samples, including the one cul-
ture-positive sample.
Discussion
Our findings show that EPEC genes were present with 
relatively high frequency in fecal samples submitted for 
bacterial culture from children with diarrhea in Ontario, 
Canada. EPEC genes were detected in more samples than 
the most prevalent pathogen detected by stool culture, Sal-
monella spp. (12 vs. 4%, respectively). This relatively high 
rate of detection of EPEC in developed country settings 
when molecular testing is used has also been reported by 
others. For example, in a study of daycare attendees in the 
Netherlands using a qPCR method, EPEC was detected 
in 19.9% of stool samples [6]. Investigators using the Bio-
fire Film Array GI panel (biomerieux) reported detecting 
eae in 15% of diarrheal samples in a European multicenter 
study and 29.49% of samples in a US study [2, 3]. The pro-
portions of t-EPEC and a-EPEC were not stated in either 
study (the bfp gene is not included in the Biofire panel), 
but most are likely to have been a-EPEC, given the low 
prevalence of t-EPEC in developed countries [1].
However, as discussed previously, it remains uncer-
tain whether a-EPEC caused the diarrhea seen in these 
patients. Other pathogens may have been present in our 
patients that were not detected by bacterial stool cultures 
performed. It is also possible that a-EPEC may be able 
to grow better in the diarrheic environment created by 
other organisms, but is not contributing to disease.
Volunteer studies have been performed to examine 
a-EPEC pathogenicity but the results of these studies 
Table 2 PCR and culture results from diarrheal fecal samples
Eae, E. coli attaching and effacing gene; EPEC, enteropathogenic E. coli; stx1, shigatoxin 1 gene; stx2, shigatoxin 2 gene; bfp, bundle-forming pilus gene; EHEC, 
enterohemorrhagic E. coli; efa1/lifA, EHEC factor for adherence 1/lymphocyte inhibitory factor A gene
PCR No. detected (%) n = 320
Eae positive 44 (14)
EPEC: eae positive/stx1 and stx2 negative 39 (12)
Atypical EPEC: eae positive/stx1 and stx2 negative/bfp negative 38 (12)
Typical EPEC: eae positive/stx1 and stx2 negative/bfp positive 1 (0.3)
EHEC: eae positive/stx1 or stx2 positive 5 (1.5)
eae positive/stx negative/efa1/lifA positive/bfp negative 16 (5)
eae positive/stx negative/efa1/lifA negative/bfp negative 22 (7)
Culture
 Salmonella spp. 13 (4)
 Campylobacter spp. 5 (1.5)
 Shigella spp. 3 (0.9)
 Plesiomonas shigelloides 3 (0.9)
 Yersinia enterocolitica 2 (0.6)
 E. coli 0157:H7 1 (0.3)
 Aeromonas spp. 1 (0.3)
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were not conclusive. For example, diarrhea occurred in 
9/10 volunteers who ingested a t-EPEC strain, but in 6/11 
who ingested an a-EPEC strain [7]. In a second study, 
11/13 adults developed diarrhea with t-EPEC ingestion, 
as compared to 5/30 who ingested bfp-negative mutant 
strains. Thus, strains lacking bfp show reduced virulence 
in adults [8]. However, interpreting these studies in the 
pediatric setting is difficult since these adult volunteers 
may have been exposed to EPEC strains earlier in life and 
developed some degree of immunity prior to the chal-
lenge study.
More recently, a strong statistical association between 
the presence of efa1/lifA-positive a-EPEC and the pres-
ence of diarrhea was noted in two studies, suggesting 
efa1/lifA-positive strains may be true diarrhea pathogens 
[9, 10]. Some research has been done that provides a bio-
logical basis for the contribution of efa1/lifA to a-EPEC 
pathogenicity. Efa1/lifA is known to be an adherence fac-
tor and, in a study by Badea, an efa1/lifA mutant EPEC 
was found to be significantly less adherent to epithelial 
cells than the parent efa1/lifA-positive strain. Addition-
ally, human and rabbit hosts infected with an attaching 
and effacing (A/E) pathogens were found to produce anti-
bodies to efa1 protein, and anti-efa1 antibodies reduced 
the adherence of efa-positive EPEC to epithelial cells [16]. 
These findings suggest that the efa1/lifA gene, in concert 
with the eae gene, may play a role in adherence of a-EPEC 
infections that could then lead to diarrhea.
We also observed that samples with efa1/lifA contained 
higher loads of a-EPEC (as measured by eae gene quanti-
tation) than efa1/lifA-negative samples. Higher bacterial 
loads have been associated with occurrence of diarrhea 
in patients with a-EPEC, so our finding of this association 
between bacterial load and the presence of efa1/lifA sug-
gests strains with efa1/lifA may be more pathogenic.
The source of a-EPEC detected in the gastrointestinal 
tract of children in our center is unknown. Interestingly, 
we detected over five times more samples with EPEC 
markers than EHEC markers (27 vs. 5), suggesting that 
children are exposed to a-EPEC than EHEC much more 
frequently in our region. A recent study reported that 
a-EPEC strains that have been associated with diarrhea 
were found frequently in chicken and chicken products, 
so it is possible that these foods may be one source of 
exposure [17].
There are several limitations to this pilot study that 
should be mentioned. First, samples from children with-
out diarrhea were not tested, so the prevalence of a-EPEC 
or efa1/lifA in asymptomatic children in our region is 
unknown. As well, we studied samples collected over 
summer months, rather than year-round, so it is possi-
ble that the frequency of EPEC detection may have been 
different with sampling over the entire year. Our study 
also assumes that the genes detected by PCR belong to 
the same stool bacterium, rather than different bacterial 
strains. For example, stool samples positive for eae and 
efa1/lifA were assumed to contain an EPEC strain that 
possesses both genes. Another limitation is that PCR 
cannot differentiate live from dead bacteria. Thus, the 
detection EPEC genes could be due to dead bacteria that 
may have been ingested but perhaps killed during cook-
ing. However, since methods to readily detect EPEC in 
culture in clinical laboratories are not available, molecu-
lar methods like PCR will likely be used as the method of 
choice for EPEC detection in clinical specimens, despite 
this drawback. Finally, we did not test fecal samples for 
viral or parasitic pathogens or for Clostridium difficile. 
Some children with EPEC detected may have had one 
of these micro-organisms in their fecal samples, which 
could suggest that EPEC may not have been the cause 
of the diarrhea in these cases. In future work, we plan to 
perform testing for these additional organisms as well as 
EPEC.
Our objective in the study was to assess whether efa1/
lifA could be directly detected by qPCR in stool samples, 
and whether efa1/lifA status was related to bacterial load. 
We now hope to be able to perform a qPCR-based case–
control study for a-EPEC and efa1/lifA that will deal with 
the limitations noted above.
Conclusion
Given our findings and previous reports regarding the 
significance of efa1/lifA, continued research into the 
role this gene plays in a-EPEC infection is needed. New 
volunteer studies comparing diarrheal symptoms in 
those ingesting efa1/lifA-positive and efa1/lifA-negative 
a-EPEC would be helpful. As noted, we hope to perform 
a case–control study in which eae and efa1/lifA will be 
examined and quantified by direct fecal qPCR in children 
with diarrhea and healthy controls.
As pointed out in a recent review, there are many other 
unanswered questions regarding EPEC [18], including 
the pathogenicity of a-EPEC and the optimum antibi-
otic treatment, if any, for patients with diarrhea in whom 
EPEC is detected. Historically, t-EPEC diarrhea in infants 
has been treated with a variety of oral antibiotics, such 
as gentamicin and colistin, with reported success [19] but 
randomized controlled trials of antibiotic treatment have 
not been performed. For a-EPEC, no information is avail-
able regarding antibiotic treatment. Given the ongoing 
shift in clinical microbiology laboratories from culture 
methods that do not detect EPEC to molecular detection 
panels that do, there is a pressing need to address these 
questions to help guide patient care.
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